GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Waters Corp (LTS:0LTI) » Definitions » Loans Receivable

Waters (LTS:0LTI) Loans Receivable : $0 Mil (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Waters Loans Receivable?

Waters's Loans Receivable for the quarter that ended in Sep. 2024 was $0 Mil.


Waters Loans Receivable Historical Data

The historical data trend for Waters's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Waters Loans Receivable Chart

Waters Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Waters Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Waters Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Waters Loans Receivable Related Terms

Thank you for viewing the detailed overview of Waters's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Waters Business Description

Traded in Other Exchanges
Address
34 Maple Street, Milford, MA, USA, 01757
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions.

Waters Headlines

No Headlines